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Abstract
Background: Transcription cofactors related to Drosophila Schnurri facilitate the transcriptional programs regulated by
BMP signaling in C. elegans, Drosophila, Xenopus, and mouse. In different systems, Schnurri homologs have been
shown to act as either agonists or antagonists of Smad function, and as either positive or negative regulators of
transcription. How Schnurri proteins achieve this diversity of activities is not clear. The C. elegans sma-9/schnurri locus
undergoes alternative splicing, including an unusual trans-splicing event that could generate two non-overlapping
shorter transcripts.
Results: We demonstrate here that the shorter transcripts are expressed in vivo. Furthermore, we find that one of the
short transcripts plays a tissue-specific role in sma-9 function, contributing to the patterning of male-specific sensory
rays, but not to the regulation of body size. Based on previous results, we suggest that this transcript encodes a Cterminal SMA-9 isoform that may provide transcriptional activation activity, while full length isoforms may mediate
transcriptional repression and/or activation in a context-dependent manner.
Conclusion: The alternative trans-splicing of sma-9 may contribute to the diversity of functions necessary to mediate
tissue-specific outputs of BMP signaling.
Background
The transforming growth factor β (TGFβ) superfamily
comprises a large number of secreted peptide growth factors that have major regulatory effects on cell growth and
differentiation [1,2]. Members of this superfamily include
the TGFβs, the prototypes of the superfamily; the bone
morphogenetic proteins (BMPs); and other members
such as activin, inhibin, and Nodal. TGFβ superfamily
ligands bind to a heteromeric receptor complex at the cell
surface. This complex contains two related transmembrane serine/threonine kinases, the type I and type II
receptors [3,4]. Signaling downstream of the receptors is
mediated by the Smad proteins, which shuttle between
the cytoplasm and nucleus to regulate target gene expression [5]. Type I receptors directly activate receptor-regulated Smads (R-Smads) by phosphorylation at C-terminal
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SXS sequences [6,7]. Phosphorylation of R-Smads promotes heterotrimeric complex formation with Co-Smads
and accumulation in the nucleus to regulate gene transcription [7-11]. In mammals, five R-Smads are present:
two (Smad2,3) that transduce TGFβ/activin/Nodal signals and three (Smad1,5,8) that transduce BMP signals.
Strikingly, the TGFβ family ligands far outnumber the
Smads available for signal transduction. Furthermore,
many of these ligands are capable of eliciting diverse context-dependent responses. Thus, Smad complexes must
be capable of mediating multiple diverse outcomes. It is
thought that Smad complexes rely in part on transcription cofactors for appropriate regulation of target genes.
In the nematode Caenorhabditis elegans, the BMPrelated factor DBL-1 regulates body size and male tail
morphogenesis via a conserved receptor/Smad signaling
pathway [12]. Using a genetic approach to uncover components of this pathway, we previously identified sma-9, a
gene that is required for the body size and male tail patterning functions of DBL-1 [13]. sma-9 is also required
for patterning of the mesodermal lineage, in which it acts
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antagonistically to the DBL-1 pathway [14]. sma-9 is predicted to encode multiple protein products homologous
to Drosophila Schnurri, a large zinc finger transcription
cofactor that functions in Dpp/BMP signaling [15,16].
Analysis of sma-9 therefore provides the opportunity to
elucidate the requirements for transcription cofactor
function in an in vivo model system during the course of
development. In addition to Drosophila Schnurri and C.
elegans SMA-9/Schnurri, three vertebrate Schnurri
homologs have been identified. These bind the κB-binding site and function in T cell development [17-19]. Notably, vertebrate Schnurri homologs have more recently
been demonstrated to mediate transcriptional regulation
downstream of BMP and TGFβ ligands, indicating a conserved role for these family members in TGFβ signal
transduction [20-22].
The sma-9 open reading frame (ORF) predicted from
genomic sequence encodes a protein of 2170 aa consisting of an N-terminal Gln-rich domain (encoded by predicted exons 1-3) and a C-terminal domain containing
seven Zn fingers (in predicted exons 12-22). The
sequencing of cDNA clones, however, revealed at least
eight different mRNA species with alternative protein
coding regions [13]. Interestingly, like sma-9, human
Shn-1 and Shn-3 genes undergo alternative splicing
[23,24], but the functional consequences of this processing have not been addressed. The sma-9 cDNA clones
were classified based on their potential to code for the
seven C-terminal Zn fingers: class I encodes all seven Zn
fingers (ZF1-7), class II encodes the first pair and the triplet of Zn fingers (ZF1-5), and class III encodes only the
first pair (ZF1-2). To determine whether these domains
have different functions in vivo, Foehr et al. created
genomic/cDNA hybrid constructs and tested their ability
to rescue the body size and mesodermal patterning
defects of sma-9 mutants [14]. They found that constructs encoding class I and class II C-termini were capable of rescuing both phenotypes, while the class III
construct was not, suggesting that the presence of the Zn
finger triplet is critical for function in body size and
mesodermal lineage regulation.
Since sma-9 is a large gene, most of the existing cDNA
clones contain incomplete coding sequences that are
missing the 5' end of the gene. Two cDNA clones,
yk1285a11 and yk1237d01, however, are notably different
(Figure 1). Although these two cDNA clones are less than
half the length of the predicted transcript, both of them
have all of the hallmarks of a full-length cDNA: transspliced leader sequence, poly(A) tail, and a complete ORF.
In C. elegans, many transcripts are processed at the 5' end
by trans-splicing, which results in the addition of a 22nucleotide splice leader sequence, SL1 or SL2 [25]. The
mechanism of trans-splicing is similar to that of cis-splicing (intron removal), except that the splice donor
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sequences are provided by the SL1 and SL2 genes, rather
than being contained within the context of the individual
gene [25]. About half of all C. elegans genes are subjected
to SL1 trans-splicing at the 5' end. A smaller subset of C.
elegans genes are transcribed in polycistronic operons. In
an operon, the 5'-most gene generally receives the SL1
splice leader. The individual downstream genes in an
operon are then separated via SL2 trans-splicing to the 5'
ends of each of the downstream genes. SL2 trans-splicing
is accompanied by polyadenylation to create the 3' end of
the neighboring gene upstream. yk1285a11 contains the
SL1 splice leader and sequences from predicted exons 17. yk1237d01 contains the SL2 splice leader and
sequences from predicted exons 11-25. As previously
noted [13], the putative intercistronic region contains
features reminiscent of the identified signals for transsplicing, including a U-rich sequence, but is atypically
long [26,27]. Thus, the structures of the sma-9 cDNA
clones yk1285a11 and yk1237d01 suggest that they may
represent two transcripts processed from a single longer
transcript by SL2 trans-splicing and polyadenylation as
normally occurs in a C. elegans polycistronic operon.
Since each of these trans-spliced short sma-9 transcripts was only represented by a single cDNA clone, we
could not be certain that the clones were not due to cloning artifacts or a rare spurious event. Furthermore, our
previous analysis did not address whether these short
transcripts provide any function required for DBL-1 signal transduction. We therefore address here several
remaining questions about these predicted transcripts.
First, can we verify that the mRNA variants represented
by yk1285a11 and yk1237d01 are expressed in vivo, rather
than being artifacts produced during cDNA library construction? If so, then how is the expression of these variants regulated? Finally, do these variants show functional
differences between each other and/or relative to fulllength transcripts in vivo? In this work, we will refer to
the splice variants represented by clones yk1285a11 (5')
and yk1237d01 (3') as A11 and D01, respectively.

Results
Isolation of cDNAs spanning upstream and downstream
regions

The sma-9 ORF predicted from genomic sequence is
encoded by 25 exons ([13]; Figure 1). Previously characterized cDNA clones, however, contained only a subset of
these 25 exons and, in particular, none of the existing
cDNA clones spanned a region including both the N-terminal Gln-rich domain and the C-terminal Zn finger
domains. We therefore used primers in exons 1 and 25
with the potential to generate nearly full-length cDNA
inserts by RT-PCR. After RT-PCR, the clones with the
longest inserts were selected for sequencing. The most
complete cDNA clone isolated by this approach was
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pCS368

Figure 1 Structure of sma-9 transcript variants. The predicted sma-9 intron-exon structure is shown above. Arrows mark positions of nonsense
codons in three sma-9 alleles. pCS386 is the most complete cDNA variant isolated to date. The two short variants represented by cDNA clones
yk1285a11 (A11) and yk1237d01 (D01) are shown below. ARD: acidic residue-rich domain; NLS: nuclear localization signal.

pCS368, in which exons 4-8 and part of exon 9 are spliced
out (Figure 1). This transcript form is reminiscent of a
form identified by the ORFeome project, in which exon 3
becomes spliced to exon 20 [28]. These results thus support the existence of sma-9 transcripts capable of encoding both the Gln-rich and the Zn finger domains.
Additional support derives from RT-PCR data using exon
9 primers (see below).
Expression of sma-9 variant transcripts

We next sought to obtain evidence that the short transcripts represented by cDNA clones yk1285a11 and
yk1237d01 (A11 and D01) are expressed in vivo, rather
than cDNA artifacts. To address this question, we needed
an approach to distinguish these short transcripts from
full-length transcripts containing the same internal
sequences. Unfortunately, we were unable to detect sma9 mRNAs by Northern blot (data not shown). Instead, we
used the unique termini of the short transcripts to design
variant-specific primer pairs for RT-PCR. For A11 we
employed an oligo-dT-containing reverse primer
anchored by two nucleotides from sma-9 exon 7 with a
gene-specific internal forward primer; for D01 we used
an SL2-containing primer anchored by two nucleotides
from sma-9 exon 11 with a gene-specific internal reverse
primer. To determine empirically whether these primer
pairs are specific for A11 and D01, we performed RTPCR using a gradient of annealing temperatures (50°C 55°C) and analyzed the products (Figure 2A). In both
cases, the primer pairs amplified a single band of the correct size (330 bp for A11 and 300 bp for D01), indicating

that the primers specifically detect the desired transcripts. Since the higher annealing temperatures resulted
in reduced yield, we used 50°C for all subsequent analyses. Based on these results, we conclude that transcripts
polyadenylated downstream of exon 7 and transcripts
containing the SL2 splice leader sequence upstream of
exon 11 are represented in the pool of sma-9 mRNAs in
vivo.
The initial RT-PCR experiments were performed nonquantitatively on mixed-stage RNA preparations. We
subsequently used real-time quantitative RT-PCR (qRTPCR) to determine the relative expression levels of sma-9
variant transcripts and whether they are developmentally
or sex-specifically regulated. Since we expect full-length
transcripts, but not the short transcripts, to contain
sequences from exon 9, we used exon 9 internal primers
to determine the expression levels of potentially fulllength transcripts and calculated the abundance of the
short transcripts relative to exon-9-containing transcripts. Three developmental time points were assayed:
24 hr (first larval stage - L1), 44 hr (approximately L3),
and 96 hr (adults). We find that exon-9-containing transcript levels increase during larval development and are
highest in adulthood (Figure 2B). D01 transcripts accumulate in wild-type strain N2 at 45% - 85% of the level of
exon-9-containing transcripts at all developmental time
points examined, while A11 transcripts accumulate at
approximately 10% of the level of exon-9-containing transcripts (Figure 2B; Table 1). If A11 and D01 are produced
concurrently by trans-splicing of full-length transcripts,
then the reduced accumulation of A11 may be due to dif-
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Figure 2 Expression of sma-9 transcript variants. A. Detection of A11 and D01 transcripts using variant-specific RT-PCR over a gradient of annealing
temperatures (left to right: 50°C - 55°C). The expected size of the PCR product is 330 bp for A11 and 300 bp for D01. B. Developmental profile of sma9 transcript expression levels, as determined by qRT-PCR. Data are shown as transcript abundance relative to act-1 actin gene control, and error bars
show standard deviation. See Table 1 for quantitation of transcript abundance relative to exon-9-containing control.

ferential stability of the transcripts. One possible mechanism for reduced stability of the A11 transcript is the
unusual location of the termination codon TAA, in which
the terminal adenines are introduced during polyadenylation and are contiguous with the poly(A) tail. To test for
sex-specific expression of these transcripts, him-5 (high
incidence of males) mutant populations that contain both
hermaphrodites and males were compared to wild-type
N2 hermaphrodite populations. In him-5 populations,
the full-length and the D01 transcripts, but not A11,
accumulate to a 2-4-fold higher level than in hermaphrodite populations, suggesting that these transcripts are
expressed at a higher level in males. The short transcripts
are not male-specific, however, since they are also
expressed in hermaphrodites. Thus, the A11 and D01
cDNA clones represent detectable mRNAs that are
expressed during larval and adult stages when DBL-1 is
active in regulating body size and male tail patterning.
Loss of function of sma-9 variant transcripts

Previous work has shown that sma-9 constructs lacking
the Zn finger triplet (ZF3-5) are unable to rescue the

body size and mesodermal patterning defects of a sma-9
mutant [14]. These experiments did not test, however, for
differential requirements of short vs. full-length transcripts. To test whether sma-9 variant transcripts have
specific functional roles, we performed RNAi targeting
three different regions of the sma-9 gene. In previous
experiments, dsRNA was introduced by microinjection
[13,14], but we have found that RNAi by feeding results in
a higher penetrance of male tail defects. We have therefore repeated these experiments using the feeding technique [29], and extended them by targeting the internal
exon 9 in addition to the 5' and 3' ends of the gene. The
effectiveness of each RNAi treatment was monitored by
the appearance of the characteristic small body size phenotype (data not shown).
As a component in the DBL-1 pathway, sma-9 mutant
phenotypes include small body size and male abnormal
phenotypes [13]. One aspect of the male abnormal phenotype in sma-9 is the fusion of male tail sensory rays 8
and 9, two of the nine bilaterally symmetrical pairs of
male-specific sensory organs. In wild-type animals, ray 89 fusions are also observed, but at a lower frequency.
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Table 1: Relative expression levels of sma-9 transcript variants
Strain

Developmental
Timepoint

A11 Transcript
Level

D01 Transcript
Level

N2

L1

10.12 ± 1.06

86.35 ± 1.17

N2

L3

8.88 ± 2.58

45.00 ± 0.87

N2

adult

8.97 ± 0.43

84.58 ± 7.82

him-5

L1

8.23 ± 0.28

87.01 ± 0.37

him-5

L3

2.18 ± 0.00

37.73 ± 0.11

sma-9(qc3);him-5

L3

6.20 ± 0.01

49.55 ± 1.29

sma-9(wk55);him-5

L3

1.81 ± 0.09

88.50 ± 1.32

sma-9(cc604);him-5

L3

9.40 ± 0.05

62.70 ± 1.26

Mean expression levels are give as percent of the expression level of exon-9-containing control, plus or minus standard deviation.

Treatment of wild-type animals with RNAi targeting
exons 1-7 caused no increase in the frequency of ray 8-9
fusions (Table 2), although the small body size phenotype
was produced. This treatment is predicted to knockdown
expression of full-length and A11 variants but not the
D01 variant. Conversely, RNAi targeting exons 21-25,
predicted to knockdown the D01 and full-length variants,
resulted in a two-fold increase in the frequency of ray 8-9
fusions (Table 2). These results are consistent with our
previous findings that RNAi of the 3' end of the gene
results in more severe male abnormal phenotypes than
inactivation of the 5' end [13]. We next compared the
male tail phenotype produced by RNAi targeting the central exon 9, predicted to inhibit full-length transcripts but
not the short transcripts. This treatment resulted in a
male tail defect of lower penetrance than that produced
by RNAi targeting the 3' end (Table 2). Since the most
severe male tail defect occurred when D01 was targeted,
these experiments suggest that D01 has a role in regulating sensory ray patterning. Full-length sma-9 products
are also predicted to function in sensory ray patterning,
since the inhibition of a central exon resulted in a partial
male abnormal phenotype.
We sought to repeat this analysis using genetic
mutants, since the RNAi treatments might cause some
nonspecific effects due to targeting of unspliced premRNA or to RNAi spreading [30,31]. We took advantage
of three sma-9 alleles containing premature termination
codons at different locations in the gene (Figure 1;
[13,14]): qc3 in predicted exon 1 (within A11), wk55 in
predicted exon 9 (between the short variants), and cc604

in predicted exon 18 (within D01). Therefore, in qc3, only
the D01 transcript is capable of encoding a functional
gene product; in wk55, both A11 and D01, but not the
full-length transcript, are capable of encoding functional
gene products; and in cc604, only the A11 transcript is
capable of encoding a functional gene product. Since
additional disruptions may occur due to nonsense-mediated decay [32], we determined the transcript expression
profile for these strains at the L3 stage (Figure 3; Table 1).
In all three mutant backgrounds, the transcript levels are
somewhat reduced compared to the him-5 control. The
reduction in transcript levels is most striking in the sma9(wk55) background (Figure 3). This severe reduction in
transcript levels is consistent with our observations that
this allele causes the most severe body size phenotype
(Table 2; [13]). Most importantly for the interpretation of
our experiments, sma-9(qc3) and sma-9(cc604) animals
express the short transcripts at detectable levels near the
normal range (Figure 3).
The usual expectation for a series of nonsense mutations is that the earliest premature termination codon will
have the most severe mutant phenotype while later termination codons may cause less severe defects if those
alleles encode partially functional gene products. For the
sma-9 alleles, the opposite result is seen in the male tail.
The allele encoding the latest termination codon, cc604,
causes the most severe male tail defect, with a frequency
of ray 8-9 fusions greater than any of the previously characterized alleles (Table 2, [13]). Since different investigators typically vary in their quantitation of ray fusion
frequencies, we also repeated measurement of the male

Yin et al. BMC Molecular Biology 2010, 11:46
http://www.biomedcentral.com/1471-2199/11/46

Page 6 of 11

Table 2: sma-9 loss of function phenotypes in male tail patterning and body size
RNAi (Exon) or Mutant

Forms Predicted to be Blocked

Frequency of Ray 8-9 Fusions1 (n)

Body Length2 (n)

none

none

18% (50)

ND

1-7

full-length, A11

20% (50)

ND

9

full-length only

29% (100)

ND

21-25

full-length, D01

36% (50)

ND

sma-9(qc3)

full-length, A11

50% (50)

692 ± 85 (43)

sma-9(wk55)

full-length only

66% (50)

566 ± 34 (31)

sma-9(cc604)

full-length, D01

72% (50)

716 ± 61 (30)

1All

male tail phenotypes are scored with him-5(e1490) in the background to increase the frequency of males.
2Body length is given in μm ± standard deviation at 96 hours after embryo collection.
ND: not determined.

tail defects of qc3 and wk55 for direct comparison. Consistent with previous results, qc3, the allele containing the
earliest termination codon, causes a mild male tail defect,
while wk55, containing a termination codon in exon 9,
results in an intermediate frequency of ray fusions (Table
2). Thus, the severity of the sensory ray defect is inversely
correlated with predicted D01 activity. The most severe
defect is manifested in cc604 mutants, in which the D01
isoform is disrupted by mutation. An intermediate frequency of ray fusions occurs in wk55 mutants, in which
the D01 transcript is expressed at reduced levels but is
not disrupted by mutation. A mild male tail defect is seen
in qc3 mutants, in which levels of D01 transcripts are
lower than in wild type but higher than in wk55 (Figure
3). Overall, with regard to male tail patterning, these
mutations form an allelic series in which their levels of
activity are the opposite of that expected.
In body size, a different result was obtained with these
three mutants (Table 2). The sma-9(wk55) mutant shows
the smallest body size. In contrast, both qc3 and cc604
produce less severe body length phenotypes that are
mutually indistinguishable (Table 2). Since qc3 and cc604
produce indistinguishable body size defects, this analysis
does not support a specific role for either the A11 or the
D01 transcript in the regulation of body size. Furthermore, the more severe body size phenotype of wk55
mutants could be due to the lower overall level of sma-9
expression in these mutants (Figure 3). The results of
body size analysis thus suggest that full-length isoforms,
rather than A11 or D01, are critical for promoting
growth. Based on our RNAi data and on the differential
effects of the three nonsense alleles on body size and male

tail development, we hypothesize that the D01 short transcript has a tissue-specific function in sensory ray development.
Rescue of sma-9 mutant phenotypes by overexpression of
D01 cDNA

Consistent with our hypothesis, we have previously demonstrated that overexpression of the D01 cDNA, but not
of A11, from a heat shock promoter can partially rescue
sma-9(wk55) mutant male tail defects [33]. In comparison, expression of sma-9 from a cosmid genomic clone
containing the entire coding region resulted in nearly
complete rescue of the ray fusion defect [13]. We next
asked whether expression of sma-9 short transcripts is
sufficient to provide normal gene function in qc3 and in
cc604 mutants, in which the A11 and the D01 transcript,
respectively, are disrupted by premature termination
codons. As before, transgenics carrying hs-sma-9 constructs were subjected to heat shock during the L3 stage
when sensory ray identities are being established [34] and
males were scored in adulthood. In cc604 mutants, which
contain a premature termination codon within the D01
transcript, expression of D01 resulted in partial rescue of
the male tail defect (Figure 4A). In contrast, overexpression of A11 in cc604 caused a slight reduction in frequency of sensory ray fusions, but this effect was not
statistically significant (p = 0.16). In qc3 mutants, in
which the A11 transcript contains a premature termination codon, we were surprised to find that overexpression
of A11 produced no change in male tail phenotype,
whereas overexpression of D01 resulted in significant rescue of the male tail defect (Figure 4A). Based on the res-
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Figure 3 Expression levels of sma-9 transcripts in mutant backgrounds. Expression levels of sma-9 transcripts as determined by qRT-PCR. Animals
were collected at the L3 stage. Data are shown as transcript abundance relative to act-1 actin gene control, and error bars show standard deviation.
See Table 1 for quantitation of transcript abundance relative to exon-9-containing transcripts. (-): transcript harbors a premature termination codon.
(+): transcript sequence is normal.

cue of male tail defects by D01 in both qc3 and cc604
mutants, we conclude that increased expression of D01
may be able to compensate partially for defective fulllength sma-9 transcripts.
Finally, we looked for evidence of A11 or D01 function
in body size regulation. The body size phenotypes of qc3
and cc604 did not support a specific role for either A11 or
D01 in body size regulation, since these two mutants have
indistinguishable sizes (Table 2). To determine whether
increased expression of A11 and/or D01 can promote
growth, we used our heat shock constructs to drive their
expression. Heat shock of transgenics in the L3 stage produced no evident changes in body size (data not shown),
so we performed heat shock earlier in development, in L1
animals, and measured body length in adulthood. In contrast to the rescue of male abnormal phenotypes by D01,
heat shock of A11 and D01 transgenics led either to a
reduction in body size or to no change in body size (Figure 4B). These results suggest that A11 and D01 do not
contribute to the growth promoting activity of sma-9. If
anything, increased expression of A11 and D01 may

interfere with the ability of gene products from fulllength transcripts to promote increases in body size.

Discussion
We have shown here that the C. elegans sma-9/schnurri
locus undergoes a novel trans-splicing process to generate two shorter transcripts, one of which has a tissue-specific function in DBL-1/BMP signaling. First, we have
demonstrated that an SL2 trans-spliced, truncated cDNA
form, yk1237d01 (D01), represents an actual mRNA that
is detectable by RT-PCR. Second, we have verified that
longer transcripts containing both the 5' and 3' ends of
the gene are also detectable by RT-PCR. Third, loss-offunction experiments (RNAi and premature termination
mutants) demonstrate that the short transcript D01 is
necessary but not sufficient for male tail patterning, since
depletion of both D01 and full-length transcripts causes a
more severe male tail patterning defect than depletion of
full-length transcripts alone. Fourth, gain-of-function
experiments (heat shock-induced overexpression) indicate that the short transcript D01 can partially rescue
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male tail but not body size defects of sma-9 mutants. In
contrast to the results on D01, we find for the yk1285a11
(A11) transcript little or no evidence of an in vivo function, as well as low abundance throughout development.
In addition, class I and II full-length transcripts and the
D01 short transcript, but not the A11 transcript, encode
the Zn finger triplet domain shown to be critical in the
regulation of body size and mesodermal patterning [14].
In Drosophila, this domain is also critical in mediating
Dpp-responsive target gene regulation [35]. The gene
product encoded by the A11 transcript lacks this domain
and may therefore not be capable of being recruited to
target genes. Why then is the A11 transcript detected at
all? One possibility is that it is generated as a byproduct
of the trans-splicing mechanism that generates D01.
Since we have shown that full-length transcripts and
D01 transcripts are each necessary but not sufficient for
male tail patterning, we must consider what differences in
molecular function are found in the respective gene products. In other organisms, Schnurri homologs have been
shown to act either as transcriptional activators
[20,21,36] or as transcriptional repressors [16,37] mediating BMP-dependent transcription. Strikingly, Yao et al.
[21] have shown by swapping Drosophila and Xenopus
Schnurri homologs that transcriptional activation or
repression activities may be context-dependent rather
than an intrinsic property of the protein. In C. elegans, we
have previously analyzed intrinsic transcriptional activities of SMA-9 protein domains using a heterologous transcription assay [33]. In these experiments, the acidic
residue-rich domain (ARD) in exon 14 exhibited transcriptional activator activity, while the N-terminal region
of SMA-9 displayed intrinsic transcriptional repressor
activity [33]. Full-length sma-9 transcripts should encode
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protein products containing both of these transcriptional
domains, so that their transcriptional activities may be
context-dependent as was described for Drosophila and
Xenopus Schnurri [21]. On the other hand, D01 transcripts encode products containing solely the transcriptional activation domain (Figure 1). We therefore
hypothesize that full-length SMA-9 isoforms function as
transcriptional repressors or activators depending on
context, while D01-encoded isoforms may be obligate
transcriptional activators. This transcriptional activation
activity may be necessary for the robust activation of
sma-9 target genes in sensory ray development, but may
be dispensable in body size regulation. Consistent with
this hypothesis, a SMA-9 Zn finger domain fusion with a
known transcriptional activator, VP16, can partially rescue the male tail defects but not the body size defects of
sma-9 mutants. In contrast to the SMA-9::VP16 fusion, a
SMA-9::enR repression domain fusion rescues body size,
suggesting that transcriptional repression is more important than activation for SMA-9 activity in body size regulation [33]. Overall, the in vivo activity of the SMA9::VP16 fusion is strikingly similar to that of the D01 isoform.
Alternative splicing is regulated by trans-acting factors
that influence the choice of splice sites. It will be of interest to determine the trans-acting factors that regulate
alternative trans-splicing of sma-9. In preliminary experiments, we tested whether sma-9 trans-splicing depends
on mec-8, which encodes an RNA recognition motif-containing protein that regulates alternative splicing in the
hypodermis [38,39]. We found that A11, D01, and exon 9containing transcript levels were all reduced 2- to 5-fold
in mec-8 mutants relative to N2 (data not shown). If mec8 were directly involved in processing the short tran-

Figure 4 Phenotypic rescue by overexpression of sma-9 short transcripts. A. Male tail phenotypes are given as frequency of fusion of rays 8 and
9 per male tail side scored. p values were calculated using a Student's t-test. *: significant difference from no cDNA control (p < 0.05). **: highly significant difference from no cDNA control (p < 0.01). The p values for experiments with A11 cDNA overexpression showed no significant difference from
controls (p = 0.59 for qc3; p = 0.16 for cc604). All strains contain him-5(e1490) to increase the proportion of males. B. Body size phenotypes. Mean body
length at 96 hours after embryo collection (adult stage) is shown. Error bars show standard deviation. Note that these strains are transgenics expressing the rol-6 marker that influences body length, so all comparisons are made between heat-shocked animals and no heat shock control rather than
using a nontransgenic control. p values were calculated using a Student's t-test. **: highly significant difference from no heat shock control (p < 0.01).
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scripts from a longer precursor, we expected to find
reciprocal changes in accumulation of the full-length
transcripts relative to short transcripts. Our results are
therefore not sufficiently clear to draw a conclusion as to
whether MEC-8 is directly involved in sma-9 trans-splicing, and additional investigations will be necessary to
identify the trans-acting factors that mediate this reaction.
A variety of genetic mechanisms exist for generating
diverse functions from a single genetic locus, including
those that affect transcript structure such as alternative
splicing, alternative transcriptional start sites, and alternative polyadenylation. One prominent example of alternative splicing is the regulation of sex determination in
Drosophila by Sex-lethal [40]. This system also uses
developmentally regulated alternative promoters. In C.
elegans, extensive use of alternative promoters leading to
different protein isoforms has been documented [41].
Alternative polyadenylation can also lead to the production of truncated protein variants, such as in the daf-4
BMP receptor gene in C. elegans, in which alternative
polyadenylation leads to the production of a secreted
negative inhibitor of DAF-4 signaling [42]. To our knowledge, alternative trans-splicing as we have characterized
it for sma-9 has not previously been reported for other
loci in C. elegans. The unique feature of this trans-splicing event is the choice between processing the transcript
via cis- or trans-splicing at the splice acceptor site of predicted exon 11. In an organism without trans-splicing, a
similar truncation could be achieved via use of a downstream transcriptional start site or via proteolytic cleavage. For example, in the Hedgehog signaling pathway,
full-length transcription factors of the Ci/Gli family are
transcriptional activators that, upon proteolytic cleavage,
are converted to transcriptional repressors [43]. We speculate that since the trans-splicing machinery exists in C.
elegans, it was available to be recruited for this unusual
role in the sma-9 locus.

Conclusions
Both C. elegans sma-9/schnurri [13] and the human
homologs Shn-1 and Shn-3 [23,24] display alternative
splicing that is predicted to result in multiple protein isoforms. For most of these isoforms, however, no specific in
vivo function has been described. We have now demonstrated a functional role for an alternatively trans-spliced
sma-9 short transcript represented by cDNA clone
yk1237d01 (D01). This transcript mediates a tissue-specific role, since it is required for sensory ray development
but not for body size regulation. Our results provide
insight into how a single genetic locus can contribute to
diverse protein functions.
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Methods
C. elegans strains and culture

Nematodes were cultured using standard methods and
grown at 20°C unless otherwise noted [44]. In addition to
strains generated in this work, the following strains were
used: N2 (wild type); LG V, him-5(e1490); LG X, sma9(qc3, wk55, cc604).
RT-PCR

RT-PCR was performed in two steps using SuperScript
III First-Strand Synthesis System (Invitrogen) and RNA
extracted from mixed-stage N2 wild-type animals. Temperature gradient PCR was performed on an Eppendorf
gradient thermal cycler (MasterCycler) following the
manufacturer's instructions.
Real time RT-PCR was performed on a LightCycler 2.0
(Roche). Data analysis software used was LightCycler
software version 4.0. Animals were collected at desired
time points and total RNA extracted by Trizol as
described [13]. SuperScriptTM III platinum two-step
qRT-PCR kit with SYBR Green (Invitrogen) was used to
perform RT-PCR. Actin gene act-1 was used as standard
control. A primer in an intron of the act-1 gene was used
to confirm the absence of genomic DNA in RNA preps.
Primer sequences for all RT-PCR experiments are available upon request.
RNAi

RNAi feeding method was performed as described [29]
after cloning sma-9 fragments into RNAi feeding vector
pPD129.36 (a gift from Dr. A. Fire). To score sensory ray
patterning, only adult males displaying a small phenotype
were collected and scored to ensure that the animals analyzed had undergone a knockdown of sma-9 activity.
Heat-shock clone constructs and generation of transgenic
animals

Two sma-9 splice variants yk1285a11 and yk1237d01
(GenBank Accession Numbers: AY390537 and
AY390550) were identified previously [13], which were
SL1- and SL2- trans-spliced cDNA clones that appeared
to represent shorter but complete mRNAs. Heat-shock
vector pPD49.83 was a kind gift from Dr. J. Liu.
yk1285a11 and yk1237d01 were cloned into pPD49.83 at
Nhe I and Kpn I sites. Transgenic nematodes were generated by microinjection of constructs (10 ng/ul) into the
gonadal syncytia of him-5 hermaphrodites, with rol-6
(100 ng/ul) as a marker [45]. Mutant strains carrying
transgenic constructs were generated by appropriate
crosses between the mutant strains and transgenic lines.
Heat-shock experiments

Gravid hermaphrodites were washed off plates with M9
buffer and collected in an Eppendorf tube. Hermaphro-
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dites were destroyed with sodium hypochlorite solution,
leaving eggs that were collected and inoculated onto
OP50-seeded plates. For body size measurement, 24
hours after egg collection, worms were collected and
transferred to a siliconized Eppendorf tube containing
100 ul of M9 buffer [44], which was placed in a circulating
water bath under the heat-shock conditions specified.
After heat-shock, worms were recovered, placed at 25°C
on OP50-seeded plates and allowed to develop to adulthood. The length of individual worms was measured
using Image-Pro Express software (Sigma) with Nomarski optics. For male tail ray examination, worms were collected 72 hours after egg collection and transferred to a
siliconized Eppendorf tube containing 100 ul of M9 buffer [44], which was placed in a circulating water bath
under the heat-shock conditions specified. After heatshock, worms were recovered, placed at 25°C on OP50seeded plates and allowed to develop to adulthood and
then scored for ray patterning.
Authors' contributions
JY performed the heat shock and RT-PCR experiments and participated in
interpretation of data. LY performed the RNAi experiments. CSD conceived of
the study, participated in its design and coordination, analyzed mutant phenotypes, and drafted the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
We thank Jun Kelly Liu for sharing reagents and for helpful discussions. Some of
the experiments were done with equipment from the Core Facilities for Imaging, Cellular and Molecular Biology at Queens College. Some C. elegans mutant
strains were obtained from the Caenorhabditis Genetics Center, which is supported by the NIH National Center for Research Resources (NCRR). This work
was carried out in partial fulfillment of the requirements for the Ph.D. degree
from the Graduate Center of City University of New York (J.Y.). This research was
supported by RSG-98-230-04-DDC from the American Cancer Society to C.S.-D.
Author Details
Department of Biology, Queens College, and Biochemistry PhD Program, the
Graduate School and University Center, the City University of New York,
Flushing, NY 11367, USA
Received: 3 March 2010 Accepted: 17 June 2010
Published: 17 June 2010

Page 10 of 11

7.

8.

9.

10.
11.

12.
13.

14.

15.

16.
17.
18.

19.
20.

21.

22.

23.

©
This
BMC
2010
is
article
Molecular
an
Yin
Open
is
etavailable
al;Biology
Access
licensee
from:
2010,
article
BioMed
http://www.biomedcentral.com/1471-2199/11/46
11:46
distributed
Central under
Ltd. the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

24.
References
1. Roberts AB, Sporn MB: Physiological actions and clinical applications of
transforming growth factor-beta (TGF-beta). Growth Factors 1993,
8(1):1-9.
2. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 2000,
14(6):627-644.
3. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF,
Massague J: TGF beta signals through a heteromeric protein kinase
receptor complex. Cell 1992, 71(6):1003-1014.
4. Liu F, Ventura F, Doody J, Massague J: Human type II receptor for bone
morphogenic proteins (BMPs): extension of the two-kinase receptor
model to the BMPs. Mol Cell Biol 1995, 15(7):3479-3486.
5. Inman GJ, Nicolas FJ, Hill CS: Nucleocytoplasmic shuttling of Smads 2, 3,
and 4 permits sensing of TGF-beta receptor activity. Mol Cell 2002,
10(2):283-294.
6. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL:
MADR2 is a substrate of the TGFbeta receptor and its phosphorylation
is required for nuclear accumulation and signaling. Cell 1996,
87(7):1215-1224.

25.
26.

27.

28.

29.
30.

Kretzschmar M, Liu F, Hata A, Doody J, Massague J: The TGF-beta family
mediator Smad1 is phosphorylated directly and activated functionally
by the BMP receptor kinase. Genes Dev 1997, 11(8):984-995.
Wu RY, Zhang Y, Feng XH, Derynck R: Heteromeric and homomeric
interactions correlate with signaling activity and functional
cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol 1997,
17(5):2521-2528.
Zhang Y, Feng X, We R, Derynck R: Receptor-associated Mad
homologues synergize as effectors of the TGF-beta response. Nature
1996, 383(6596):168-172.
Inman GJ, Hill CS: Stoichiometry of active smad-transcription factor
complexes on DNA. J Biol Chem 2002, 277(52):51008-51016.
Lagna G, Hata A, Hemmati-Brivanlou A, Massague J: Partnership between
DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature
1996, 383(6603):832-836.
Savage-Dunn C: TGF-β signaling. WormBook 2005, 9:1-12.
Liang J, Lints R, Foehr ML, Tokarz R, Yu L, Emmons SW, Liu J, Savage-Dunn
C: The Caenorhabditis elegans schnurri homolog sma-9 mediates
stage- and cell type-specific responses to DBL-1 BMP-related signaling.
Development 2003, 130(26):6453-6464.
Foehr ML, Lindy AS, Fairbank RC, Amin NM, Xu M, Yanowitz J, Fire AZ, Liu J:
An antagonistic role for the C. elegans Schnurri homolog SMA-9 in
modulating TGFbeta signaling during mesodermal patterning.
Development 2006, 133(15):2887-2896.
Dai H, Hogan C, Gopalakrishnan B, Torres-Vazquez J, Nguyen M, Park S,
Raftery LA, Warrior R, Arora K: The zinc finger protein schnurri acts as a
Smad partner in mediating the transcriptional response to
decapentaplegic. Dev Biol 2000, 227(2):373-387.
Marty T, Muller B, Basler K, Affolter M: Schnurri mediates Dpp-dependent
repression of brinker transcription. Nat Cell Biol 2000, 2(10):745-749.
Takagi T, Harada J, Ishii S: Murine Schnurri-2 is required for positive
selection of thymocytes. Nat Immunol 2001, 2(11):1048-1053.
Oukka M, Kim ST, Lugo G, Sun J, Wu LC, Glimcher LH: A mammalian
homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven
responses and interacts with TRAF2. Mol Cell 2002, 9(1):121-131.
Wu LC: ZAS: C2H2 zinc finger proteins involved in growth and
development. Gene Expr 2002, 10(4):137-152.
Jin W, Takagi T, Kanesashi SN, Kurahashi T, Nomura T, Harada J, Ishii S:
Schnurri-2 controls BMP-dependent adipogenesis via interaction with
Smad proteins. Dev Cell 2006, 10(4):461-471.
Yao LC, Blitz IL, Peiffer DA, Phin S, Wang Y, Ogata S, Cho KW, Arora K,
Warrior R: Schnurri transcription factors from Drosophila and
vertebrates can mediate Bmp signaling through a phylogenetically
conserved mechanism. Development 2006, 133(20):4025-4034.
Shukla A, Malik M, Cataisson C, Ho Y, Friesen T, Suh KS, Yuspa SH: TGF-beta
signalling is regulated by Schnurri-2-dependent nuclear translocation
of CLIC4 and consequent stabilization of phospho-Smad2 and 3. Nat
Cell Biol 2009, 11(6):777-784.
Muchardt C, Seeler JS, Nirula A, Shurland DL, Gaynor RB: Regulation of
human immunodeficiency virus enhancer function by PRDII-BF1 and
c-rel gene products. J Virol 1992, 66(1):244-250.
Hicar MD, Liu Y, Allen CE, Wu LC: Structure of the human zinc finger
protein HIVEP3: molecular cloning, expression, exon-intron structure,
and comparison with paralogous genes HIVEP1 and HIVEP2. Genomics
2001, 71(1):89-100.
Blumenthal T: Trans-splicing and operons. WormBook 2005, 25:1-9.
Huang T, Kuersten S, Deshpande AM, Spieth J, MacMorris M, Blumenthal
T: Intercistronic region required for polycistronic pre-mRNA processing
in Caenorhabditis elegans. Mol Cell Biol 2001, 21(4):1111-1120.
Blumenthal T, Evans D, Link CD, Guffanti A, Lawson D, Thierry-Mieg J,
Thierry-Mieg D, Chiu WL, Duke K, Kiraly M, et al.: A global analysis of
Caenorhabditis elegans operons. Nature 2002, 417(6891):851-854.
Lamesch P, Milstein S, Hao T, Rosenberg J, Li N, Sequerra R, Bosak S,
Doucette-Stamm L, Vandenhaute J, Hill DE, et al.: C. elegans ORFeome
version 3.1: increasing the coverage of ORFeome resources with
improved gene predictions. Genome Res 2004, 14(10B):2064-2069.
Kamath RS, Ahringer J: Genome-wide RNAi screening in Caenorhabditis
elegans. Methods 2003, 30(4):313-321.
Sijen T, Fleenor J, Simmer F, Thijssen KL, Parrish S, Timmons L, Plasterk RH,
Fire A: On the role of RNA amplification in dsRNA-triggered gene
silencing. Cell 2001, 107(4):465-476.

Yin et al. BMC Molecular Biology 2010, 11:46
http://www.biomedcentral.com/1471-2199/11/46

31. Bosher JM, Dufourcq P, Sookhareea S, Labouesse M: RNA interference
can target pre-mRNA: consequences for gene expression in a
Caenorhabditis elegans operon. Genetics 1999, 153(3):1245-1256.
32. Mango SE: Stop making nonSense: the C. elegans smg genes. Trends
Genet 2001, 17(11):646-653.
33. Liang J, Yu L, Yin J, Savage-Dunn C: Transcriptional repressor and
activator activities of SMA-9 contribute differentially to BMP-related
signaling outputs. Dev Biol 2007, 305(2):714-725.
34. Lints R, Emmons SW: Patterning of dopaminergic neurotransmitter
identity among Caenorhabditis elegans ray sensory neurons by a
TGFbeta family signaling pathway and a Hox gene. Development 1999,
126(24):5819-5831.
35. Muller B, Hartmann B, Pyrowolakis G, Affolter M, Basler K: Conversion of an
extracellular Dpp/BMP morphogen gradient into an inverse
transcriptional gradient. Cell 2003, 113(2):221-233.
36. Torres-Vazquez J, Park S, Warrior R, Arora K: The transcription factor
Schnurri plays a dual role in mediating Dpp signaling during
embryogenesis. Development 2001, 128(9):1657-1670.
37. Pyrowolakis G, Hartmann B, Muller B, Basler K, Affolter M: A simple
molecular complex mediates widespread BMP-induced repression
during Drosophila development. Dev Cell 2004, 7(2):229-240.
38. Spike CA, Davies AG, Shaw JE, Herman RK: MEC-8 regulates alternative
splicing of unc-52 transcripts in C. elegans hypodermal cells.
Development 2002, 129(21):4999-5008.
39. Lundquist EA, Herman RK, Rogalski TM, Mullen GP, Moerman DG, Shaw JE:
The mec-8 gene of C. elegans encodes a protein with two RNA
recognition motifs and regulates alternative splicing of unc-52
transcripts. Development 1996, 122(5):1601-1610.
40. Black DL: Mechanisms of alternative pre-messenger RNA splicing.
Annu Rev Biochem 2003, 72:291-336.
41. Choi J, Newman AP: A two-promoter system of gene expression in C.
elegans. Dev Biol 2006, 296(2):537-544.
42. Gunther CV, Riddle DL: Alternative polyadenylation results in a
truncated daf-4 BMP receptor that antagonizes DAF-7-mediated
development in Caenorhabditis elegans. J Biol Chem 2004,
279(38):39555-39564.
43. Huangfu D, Anderson KV: Signaling from Smo to Ci/Gli: conservation
and divergence of Hedgehog pathways from Drosophila to
vertebrates. Development 2006, 133(1):3-14.
44. Brenner S: The genetics of Caenorhabditis elegans. Genetics 1974,
77(1):71-94.
45. Mello CC, Kramer JM, Stinchcomb D, Ambros V: Efficient gene transfer in
C.elegans: extrachromosomal maintenance and integration of
transforming sequences. Embo J 1991, 10(12):3959-3970.
doi: 10.1186/1471-2199-11-46
Cite this article as: Yin et al., Alternative trans-splicing of Caenorhabditis elegans sma-9/schnurri generates a short transcript that provides tissue-specific
function in BMP signaling BMC Molecular Biology 2010, 11:46

Page 11 of 11

